Rachid Karam

3.8k total citations
37 papers, 1.6k citations indexed

About

Rachid Karam is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Rachid Karam has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Rachid Karam's work include Genetic factors in colorectal cancer (12 papers), Genomics and Rare Diseases (10 papers) and RNA Research and Splicing (10 papers). Rachid Karam is often cited by papers focused on Genetic factors in colorectal cancer (12 papers), Genomics and Rare Diseases (10 papers) and RNA Research and Splicing (10 papers). Rachid Karam collaborates with scholars based in United States, Portugal and Canada. Rachid Karam's co-authors include Miles Wilkinson, Lulu Huang, Eleen Y. Shum, Hye-Won Song, Lawrence B. Gardner, Cláudio Galleano Zettler, Andréa Pires Souto Damin, Cláudio Osmar Pereira Alexandre, Maira Caleffi and Jordan Wengrod and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Molecular Cell.

In The Last Decade

Rachid Karam

34 papers receiving 1.6k citations

Peers

Rachid Karam
Shalini C. Reshmi United States
Annabelle Lewis United Kingdom
Sabina Solinas‐Toldo Germany
Bob Argiropoulos Canada
Alexandra Bell United Kingdom
Madhvi B. Upender United States
Lamis Yehia United States
Ivana L. de la Serna United States
Isabelle Tournier France
Naoki Kakazu Japan
Shalini C. Reshmi United States
Rachid Karam
Citations per year, relative to Rachid Karam Rachid Karam (= 1×) peers Shalini C. Reshmi

Countries citing papers authored by Rachid Karam

Since Specialization
Citations

This map shows the geographic impact of Rachid Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachid Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachid Karam more than expected).

Fields of papers citing papers by Rachid Karam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachid Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachid Karam. The network helps show where Rachid Karam may publish in the future.

Co-authorship network of co-authors of Rachid Karam

This figure shows the co-authorship network connecting the top 25 collaborators of Rachid Karam. A scholar is included among the top collaborators of Rachid Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachid Karam. Rachid Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, Colin C., Carolyn Horton, Bhuvan Molparia, et al.. (2024). Solving Missing Heritability in Patients With Familial Adenomatous Polyposis With DNA-RNA Paired Testing. JCO Precision Oncology. 8(8). e2300404–e2300404. 3 indexed citations
2.
Horton, Carolyn, Lily Hoang, Heather Zimmermann, et al.. (2023). Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing. JAMA Oncology. 10(2). 212–212. 14 indexed citations
3.
Iversen, Edwin S., Steven N. Hart, Kun Y. Lee, et al.. (2022). An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance. npj Genomic Medicine. 7(1). 35–35. 4 indexed citations
4.
Lerner, Benjamin A., et al.. (2022). Simplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants. Journal of Medical Genetics. 60(1). 36–40. 5 indexed citations
5.
Scott, Anthony, et al.. (2022). Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome. Genome biology. 23(1). 266–266. 18 indexed citations
6.
Farach, Laura S., Rachid Karam, Mary C. Farach‐Carson, et al.. (2022). Massive macroglossia, a rare side effect of COVID-19: clinical, histologic, and genomic findings in COVID-19-positive versus COVID-19-negative patients. Oral and Maxillofacial Surgery. 26(4). 613–618. 3 indexed citations
7.
Hernandez, Felicia, et al.. (2021). Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data. Molecular Case Studies. 8(1). a006152–a006152. 1 indexed citations
8.
Ichikawa, Shoji, Susan E. Prockop, Charlotte Cunningham‐Rundles, et al.. (2020). Reticular dysgenesis caused by an intronic pathogenic variant in AK2. Molecular Case Studies. 6(3). a005017–a005017. 1 indexed citations
9.
Hernandez, Felicia, et al.. (2019). RNA Analysis Identifies Pathogenic Duplications in MSH2 in Patients With Lynch Syndrome. Gastroenterology. 156(6). 1924–1925.e4. 5 indexed citations
10.
Xicola, Rosa M., Shuwei Li, Rachid Karam, et al.. (2019). Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. Journal of Medical Genetics. 56(12). 838–843. 75 indexed citations
11.
Dutil, Julie, Jamie K. Teer, Volha A. Golubeva, et al.. (2019). Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico. Scientific Reports. 9(1). 17769–17769. 14 indexed citations
12.
Mester, Jessica L., Rajarshi Ghosh, Tina Pesaran, et al.. (2018). Gene‐specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel. Human Mutation. 39(11). 1581–1592. 89 indexed citations
13.
Krempely, Kate & Rachid Karam. (2018). A novel de novo CDH1 germline variant aids in the classification of carboxy-terminal E-cadherin alterations predicted to escape nonsense-mediated mRNA decay. Molecular Case Studies. 4(4). a003012–a003012. 8 indexed citations
14.
Richardson, Marcy E., Hansook Kim Chong, Wenbo Mu, et al.. (2018). DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes. Genetics in Medicine. 21(3). 683–693. 15 indexed citations
15.
Karam, Rachid, Tina Pesaran, & Elizabeth Chao. (2015). ClinGen and Genetic Testing.. New England Journal of Medicine. 373(14). 1376–1377. 1 indexed citations
16.
Liu, Chen, Rachid Karam, Yingqi Zhou, et al.. (2014). The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nature Medicine. 20(6). 596–598. 99 indexed citations
17.
Karam, Rachid, Jordan Wengrod, Lawrence B. Gardner, & Miles Wilkinson. (2013). Regulation of nonsense-mediated mRNA decay: Implications for physiology and disease. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1829(6-7). 624–633. 96 indexed citations
18.
Huang, Lulu, Waikin Chan, Eleen Y. Shum, et al.. (2011). RNA Homeostasis Governed by Cell Type-Specific and Branched Feedback Loops Acting on NMD. Molecular Cell. 43(6). 950–961. 171 indexed citations
19.
Oliveíra, Carla, Sónia Sousa, Hugo Pinheiro, et al.. (2009). Quantification of Epigenetic and Genetic 2nd Hits in CDH1 During Hereditary Diffuse Gastric Cancer Syndrome Progression. Gastroenterology. 136(7). 2137–2148. 125 indexed citations
20.
Karam, Rachid, Joana Carvalho, Irene Bruno, et al.. (2008). The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers. Oncogene. 27(30). 4255–4260. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shalini C. Reshmi Breakdown of academic impact, for papers by Annabelle Lewis Breakdown of academic impact, for papers by Sabina Solinas‐Toldo Breakdown of academic impact, for papers by Bob Argiropoulos Breakdown of academic impact, for papers by Alexandra Bell Breakdown of academic impact, for papers by Madhvi B. Upender Breakdown of academic impact, for papers by Lamis Yehia Breakdown of academic impact, for papers by Ivana L. de la Serna Breakdown of academic impact, for papers by Isabelle Tournier Breakdown of academic impact, for papers by Naoki Kakazu
Rankless by CCL
2026